MedPath

Enteropathogenic Escherichia Coli (EPEC): Does it Have a Role in Colorectal Tumourigenesis?

Completed
Conditions
Enteropathogenic Escherichia Coli .
Colorectal Carcinoma
Interventions
Other: colonoscopic biopsies
Registration Number
NCT02373020
Lead Sponsor
Mansoura University
Brief Summary

Despite the characterization of many aetiologic genetic changes. The specific causative factors in the development of sporadic colorectal cancer remain unclear. This study was performed to detect the possible role of Enteropathogenic Escherichia coli (EPEC) in developing colorectal carcinoma.

Detailed Description

Fresh biopsy specimens have been obtained from the colonic mucosa overlying the colorectal cancer as well as from the colon of the healthy controls. Culture, genotyping and virulence of EPEC were done using (nutrient broth culture, and PCR). Strains biochemically identified as E. coli were selected from the surface of a MacConkey's plate and were serogrouped by slide agglutination tests

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • patients with colorectal carcinoma after have been diagnosed
Exclusion Criteria
  • Patients with inflammatory bowel disease (IBD) or macroscopic signs of inflammation were excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
group 1colonoscopic biopsiescolonoscopic biopsies from patients with colorectal cancer patients
(Group 2colonoscopic biopsiescolonoscopic biopsies from healthy controls
Primary Outcome Measures
NameTimeMethod
virulence genes: eaeA, bfpA and stx. PCR1 week

E. coli colonies isolated from the mucosa of colorectal cancers and from healthy controls were harvested and subjected to DNA extraction (QIAGEN)

Secondary Outcome Measures
NameTimeMethod
EPEC serogrouping:1 week

Strains biochemically identified as E. coli were selected from the surface of a MacConkey's plate and were serogrouped by slide agglutination tests to detect EPEC using O-specific nonavalent E.coli antiserum (O26, O55, O86, O111, O114, O119, O124, O125, O126, O127, O128, O142), according to the manufacturer's instructions (Bio-Rad).

Strains: OF E COLI1 week

The specimens were immediately transferred to the lab, inoculated in nutrient broth and vortexed for a few seconds then incubated overnight. The following day the broth culture was subcultured on enteric isolation media. Identification of E. coli was carried out by using standard biochemical methods.

Trial Locations

Locations (1)

Mansoura University

🇪🇬

Mansoura, Egypt

© Copyright 2025. All Rights Reserved by MedPath